

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.41283407 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.32433112 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.32433112 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.66076357 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.46492049 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46286695 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46286695 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.33208496 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.17016583 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00210194 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.90877292 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 4.50117002 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 4.45928787 |
| 14 | response to peptidoglycan (GO:0032494) | 4.36971636 |
| 15 | leukocyte aggregation (GO:0070486) | 4.29806615 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.28932444 |
| 17 | detection of other organism (GO:0098543) | 4.27787718 |
| 18 | T cell migration (GO:0072678) | 4.17897709 |
| 19 | response to interleukin-15 (GO:0070672) | 4.15652026 |
| 20 | * negative T cell selection (GO:0043383) | 4.14019543 |
| 21 | tolerance induction (GO:0002507) | 4.06300539 |
| 22 | detection of bacterium (GO:0016045) | 4.01969850 |
| 23 | interferon-gamma production (GO:0032609) | 4.00573861 |
| 24 | * negative thymic T cell selection (GO:0045060) | 4.00315325 |
| 25 | * positive thymic T cell selection (GO:0045059) | 3.90006911 |
| 26 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.85615568 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.83157684 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.77037018 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.73930442 |
| 30 | microglial cell activation (GO:0001774) | 3.72419779 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.71954159 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70596210 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67716017 |
| 34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.66312321 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.66045814 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.65473137 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64318831 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.64318831 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64318831 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64318831 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64318831 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.64318831 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.63424779 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.59532607 |
| 45 | positive regulation of granulocyte differentiation (GO:0030854) | 3.55969835 |
| 46 | response to host immune response (GO:0052572) | 3.52133532 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52133532 |
| 48 | * T cell selection (GO:0045058) | 3.51731798 |
| 49 | * thymic T cell selection (GO:0045061) | 3.50971316 |
| 50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.49167736 |
| 51 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.43580960 |
| 52 | mast cell activation (GO:0045576) | 3.42779450 |
| 53 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.42642450 |
| 54 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.41981272 |
| 55 | * positive T cell selection (GO:0043368) | 3.41210806 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.36288184 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.35623341 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.34139899 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 3.33977482 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33406063 |
| 61 | T cell homeostasis (GO:0043029) | 3.32265570 |
| 62 | macrophage activation (GO:0042116) | 3.31809798 |
| 63 | mature B cell differentiation (GO:0002335) | 3.31281430 |
| 64 | * myeloid cell activation involved in immune response (GO:0002275) | 3.30478959 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.30472637 |
| 66 | positive regulation of isotype switching (GO:0045830) | 3.29295621 |
| 67 | leukocyte cell-cell adhesion (GO:0007159) | 3.28227765 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.27499100 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.27459947 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26292997 |
| 71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25790886 |
| 72 | response to host (GO:0075136) | 3.25790886 |
| 73 | response to host defenses (GO:0052200) | 3.25790886 |
| 74 | activated T cell proliferation (GO:0050798) | 3.24024241 |
| 75 | T cell receptor signaling pathway (GO:0050852) | 3.21266673 |
| 76 | B cell homeostasis (GO:0001782) | 3.19836098 |
| 77 | T cell costimulation (GO:0031295) | 3.18607452 |
| 78 | lymphocyte homeostasis (GO:0002260) | 3.16663040 |
| 79 | B cell mediated immunity (GO:0019724) | 3.16117280 |
| 80 | lymphocyte costimulation (GO:0031294) | 3.13266230 |
| 81 | negative regulation of phagocytosis (GO:0050765) | 3.12204419 |
| 82 | cellular extravasation (GO:0045123) | 3.12139485 |
| 83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11954658 |
| 84 | germinal center formation (GO:0002467) | 3.10474942 |
| 85 | regulation of mast cell activation (GO:0033003) | 3.09841139 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09706481 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09296717 |
| 88 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.09052585 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 3.07373407 |
| 90 | neutrophil activation (GO:0042119) | 3.06836837 |
| 91 | neutrophil mediated immunity (GO:0002446) | 3.05741391 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05641502 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 3.04840050 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.02958509 |
| 95 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.02726235 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.00075038 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.95329130 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94171953 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93564405 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93564405 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91830381 |
| 102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91350005 |
| 103 | response to type I interferon (GO:0034340) | 2.90457508 |
| 104 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90215311 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 2.90010973 |
| 106 | leukocyte degranulation (GO:0043299) | 2.89455152 |
| 107 | B cell proliferation (GO:0042100) | 2.87577437 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87350940 |
| 109 | regulation of granulocyte differentiation (GO:0030852) | 2.86608248 |
| 110 | mast cell degranulation (GO:0043303) | 2.85479807 |
| 111 | mast cell activation involved in immune response (GO:0002279) | 2.85479807 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.85090160 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.85090160 |
| 114 | positive regulation of DNA recombination (GO:0045911) | 2.84839390 |
| 115 | positive regulation of mast cell degranulation (GO:0043306) | 2.84822220 |
| 116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84822220 |
| 117 | positive regulation of tolerance induction (GO:0002645) | 2.84305697 |
| 118 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83196238 |
| 119 | granulocyte activation (GO:0036230) | 2.83037601 |
| 120 | defense response to protozoan (GO:0042832) | 2.82119764 |
| 121 | positive regulation of humoral immune response (GO:0002922) | 2.81533517 |
| 122 | respiratory burst (GO:0045730) | 2.81350190 |
| 123 | response to protozoan (GO:0001562) | 2.80819462 |
| 124 | positive regulation of B cell activation (GO:0050871) | 2.80725774 |
| 125 | natural killer cell differentiation (GO:0001779) | 2.80266787 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80253080 |
| 127 | negative regulation of T cell mediated immunity (GO:0002710) | 2.80234998 |
| 128 | natural killer cell activation (GO:0030101) | 2.79062052 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.78718957 |
| 130 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78170869 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78170869 |
| 132 | leukocyte homeostasis (GO:0001776) | 2.77657997 |
| 133 | macrophage activation involved in immune response (GO:0002281) | 2.76538461 |
| 134 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.74198282 |
| 135 | regulation of tolerance induction (GO:0002643) | 2.73734480 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73420183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.34088343 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91757297 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.80008101 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.07820397 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.06415063 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74737991 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.71960287 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16913670 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13713476 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11909971 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08167631 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05920208 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 3.05556539 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05352975 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95388794 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.95042402 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.91610384 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82698567 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77554472 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.76210214 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74712760 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67844324 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66967883 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.50501973 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.43111442 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41028239 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.34779976 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29104190 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25568147 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19471135 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12316723 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11788820 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11207287 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08391604 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03151882 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97904276 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.94084020 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.84222982 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78015790 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75944334 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74392056 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71183012 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70524682 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69706645 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68455726 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67497089 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60633400 |
| 48 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60467822 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.58601584 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54989648 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54533502 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49566421 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46395448 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46328201 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42353444 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40733232 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40034214 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39322074 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38262788 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33810640 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30996548 |
| 62 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30027328 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25621340 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23382044 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22423081 |
| 66 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21300488 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20540477 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19612237 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18965761 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17417296 |
| 71 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15781123 |
| 72 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14695100 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14455411 |
| 74 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.13845565 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11150155 |
| 76 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10575928 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08595706 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08212972 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07979389 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06388363 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06064410 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06047368 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03891196 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01097539 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98156658 |
| 86 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97126899 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96082695 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92322662 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92006996 |
| 90 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90452992 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84373178 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83452234 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81388825 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80871191 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80243366 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79666000 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79215997 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76957982 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76662076 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76443651 |
| 101 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.76254067 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76029201 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75784860 |
| 104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75407891 |
| 105 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.74739761 |
| 106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74224919 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71941725 |
| 108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69959238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.07526920 |
| 2 | MP0005671_abnormal_response_to | 3.55802691 |
| 3 | MP0001800_abnormal_humoral_immune | 3.33450494 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.26083690 |
| 5 | MP0005387_immune_system_phenotype | 3.10387366 |
| 6 | MP0001790_abnormal_immune_system | 3.10387366 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.91655785 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.91131834 |
| 9 | * MP0000685_abnormal_immune_system | 2.89774946 |
| 10 | MP0003436_decreased_susceptibility_to | 2.83533396 |
| 11 | MP0002723_abnormal_immune_serum | 2.80021090 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.74355791 |
| 13 | * MP0001819_abnormal_immune_cell | 2.71680422 |
| 14 | MP0003303_peritoneal_inflammation | 2.65591037 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.62894981 |
| 16 | MP0005025_abnormal_response_to | 2.55550792 |
| 17 | * MP0002398_abnormal_bone_marrow | 2.55512003 |
| 18 | MP0009785_altered_susceptibility_to | 2.53930679 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.52387378 |
| 20 | * MP0002419_abnormal_innate_immunity | 2.51266266 |
| 21 | MP0006082_CNS_inflammation | 2.39419577 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.32736805 |
| 23 | * MP0000716_abnormal_immune_system | 2.30525521 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.24579808 |
| 25 | MP0002405_respiratory_system_inflammati | 2.23069941 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.21138301 |
| 27 | * MP0000689_abnormal_spleen_morphology | 2.16630163 |
| 28 | MP0001873_stomach_inflammation | 2.08393783 |
| 29 | * MP0002722_abnormal_immune_system | 2.07343786 |
| 30 | * MP0002396_abnormal_hematopoietic_system | 1.99712501 |
| 31 | MP0002006_tumorigenesis | 1.98066301 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.97748645 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.94687456 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.94060907 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.93025693 |
| 36 | * MP0002429_abnormal_blood_cell | 1.92668609 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.91229207 |
| 38 | MP0008260_abnormal_autophagy | 1.91037863 |
| 39 | MP0004947_skin_inflammation | 1.88104893 |
| 40 | MP0004510_myositis | 1.76474522 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.76251595 |
| 42 | MP0009278_abnormal_bone_marrow | 1.70171270 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.70167976 |
| 44 | MP0003724_increased_susceptibility_to | 1.69796918 |
| 45 | MP0005451_abnormal_body_composition | 1.69128565 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.67874762 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.67210523 |
| 48 | MP0001853_heart_inflammation | 1.66458196 |
| 49 | MP0003866_abnormal_defecation | 1.60736336 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.59189579 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.59189579 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.42428403 |
| 53 | MP0002933_joint_inflammation | 1.41843518 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.37224716 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.31739367 |
| 56 | MP0000858_altered_metastatic_potential | 1.29061120 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.27492518 |
| 58 | MP0005310_abnormal_salivary_gland | 1.27048992 |
| 59 | MP0008469_abnormal_protein_level | 1.27023280 |
| 60 | MP0000490_abnormal_crypts_of | 1.24554832 |
| 61 | MP0003448_altered_tumor_morphology | 1.21327698 |
| 62 | MP0004883_abnormal_blood_vessel | 1.20187031 |
| 63 | MP0001851_eye_inflammation | 1.12665828 |
| 64 | MP0010307_abnormal_tumor_latency | 1.10364720 |
| 65 | MP0003690_abnormal_glial_cell | 1.04861178 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.01055785 |
| 67 | MP0008057_abnormal_DNA_replication | 0.99715764 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.96822304 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 0.96094623 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.95870892 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.90826670 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.89467162 |
| 73 | MP0000371_diluted_coat_color | 0.86099349 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.85129518 |
| 75 | MP0010094_abnormal_chromosome_stability | 0.84024358 |
| 76 | MP0002132_abnormal_respiratory_system | 0.83470452 |
| 77 | MP0005164_abnormal_response_to | 0.81907481 |
| 78 | MP0003077_abnormal_cell_cycle | 0.80713794 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.77797737 |
| 80 | MP0002009_preneoplasia | 0.77327299 |
| 81 | MP0000343_altered_response_to | 0.76859642 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73651628 |
| 83 | MP0003045_fibrosis | 0.73032865 |
| 84 | * MP0009763_increased_sensitivity_to | 0.69833002 |
| 85 | MP0009764_decreased_sensitivity_to | 0.69136896 |
| 86 | MP0008004_abnormal_stomach_pH | 0.68361084 |
| 87 | MP0004381_abnormal_hair_follicle | 0.68292647 |
| 88 | MP0005023_abnormal_wound_healing | 0.66909627 |
| 89 | MP0002928_abnormal_bile_duct | 0.64827866 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.63918636 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.63196475 |
| 92 | MP0005166_decreased_susceptibility_to | 0.62772872 |
| 93 | MP0008058_abnormal_DNA_repair | 0.62134054 |
| 94 | MP0000249_abnormal_blood_vessel | 0.61816139 |
| 95 | MP0001663_abnormal_digestive_system | 0.59975881 |
| 96 | MP0003828_pulmonary_edema | 0.59921224 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.59823597 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.59798062 |
| 99 | MP0000313_abnormal_cell_death | 0.59531570 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.58939595 |
| 101 | * MP0003091_abnormal_cell_migration | 0.58637781 |
| 102 | MP0009840_abnormal_foam_cell | 0.58243838 |
| 103 | MP0003795_abnormal_bone_structure | 0.57255176 |
| 104 | MP0009115_abnormal_fat_cell | 0.55523376 |
| 105 | MP0000604_amyloidosis | 0.54669631 |
| 106 | MP0003111_abnormal_nucleus_morphology | 0.53348903 |
| 107 | * MP0009765_abnormal_xenobiotic_induced | 0.53199812 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.52702280 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.52246846 |
| 110 | MP0008874_decreased_physiological_sensi | 0.51888698 |
| 111 | MP0005390_skeleton_phenotype | 0.50976386 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.50861451 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.50532235 |
| 114 | MP0004130_abnormal_muscle_cell | 0.50162923 |
| 115 | MP0000609_abnormal_liver_physiology | 0.49183801 |
| 116 | MP0003075_altered_response_to | 0.47630948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.26949057 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.75114004 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.58649493 |
| 4 | Recurrent viral infections (HP:0004429) | 4.57077626 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.53319883 |
| 6 | T lymphocytopenia (HP:0005403) | 4.47547700 |
| 7 | IgM deficiency (HP:0002850) | 4.31147934 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.26975860 |
| 9 | Myositis (HP:0100614) | 4.08159878 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04149427 |
| 11 | Chronic otitis media (HP:0000389) | 3.97649420 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.90766432 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.82634933 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.70370036 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.70370036 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.70350926 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.69622084 |
| 18 | Recurrent skin infections (HP:0001581) | 3.60066239 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.58406381 |
| 20 | Nasal polyposis (HP:0100582) | 3.55642781 |
| 21 | Meningitis (HP:0001287) | 3.54404507 |
| 22 | Abnormality of T cells (HP:0002843) | 3.51936356 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.48707490 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.48462222 |
| 25 | Cellulitis (HP:0100658) | 3.46553329 |
| 26 | Colitis (HP:0002583) | 3.38187931 |
| 27 | Stomatitis (HP:0010280) | 3.36355086 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.35621351 |
| 29 | Thyroiditis (HP:0100646) | 3.35374521 |
| 30 | Abnormality of the fingertips (HP:0001211) | 3.28781899 |
| 31 | Pustule (HP:0200039) | 3.21884798 |
| 32 | Vasculitis (HP:0002633) | 3.21859283 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.18193515 |
| 34 | Optic neuritis (HP:0100653) | 3.18193515 |
| 35 | Orchitis (HP:0100796) | 3.08091785 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.07842172 |
| 37 | Obstructive lung disease (HP:0006536) | 3.07081453 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07081453 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05725175 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 3.03028021 |
| 41 | Leukocytosis (HP:0001974) | 3.00001179 |
| 42 | Periodontitis (HP:0000704) | 2.98597664 |
| 43 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.94228207 |
| 44 | B lymphocytopenia (HP:0010976) | 2.92293175 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.92293175 |
| 46 | Urticaria (HP:0001025) | 2.90834719 |
| 47 | Lymphopenia (HP:0001888) | 2.90348260 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.89950583 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.88657248 |
| 50 | Eosinophilia (HP:0001880) | 2.88441998 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.87365302 |
| 52 | Abnormality of eosinophils (HP:0001879) | 2.84261781 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.83500930 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.81626433 |
| 55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.78835657 |
| 56 | IgG deficiency (HP:0004315) | 2.77139117 |
| 57 | Combined immunodeficiency (HP:0005387) | 2.73905954 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.71666058 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.71012755 |
| 60 | Thrombocytosis (HP:0001894) | 2.68015670 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.67464540 |
| 62 | Gingivitis (HP:0000230) | 2.66561131 |
| 63 | Verrucae (HP:0200043) | 2.64604133 |
| 64 | Papilloma (HP:0012740) | 2.64604133 |
| 65 | Chronic diarrhea (HP:0002028) | 2.63937064 |
| 66 | Arterial thrombosis (HP:0004420) | 2.63186123 |
| 67 | Viral hepatitis (HP:0006562) | 2.59744091 |
| 68 | Granulocytopenia (HP:0001913) | 2.58194085 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.57310746 |
| 70 | Epistaxis (HP:0000421) | 2.57133506 |
| 71 | Osteomyelitis (HP:0002754) | 2.53450072 |
| 72 | IgA deficiency (HP:0002720) | 2.53140424 |
| 73 | Encephalitis (HP:0002383) | 2.51403581 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46239118 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46239118 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46239118 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.41396092 |
| 78 | Increased IgE level (HP:0003212) | 2.38560476 |
| 79 | Hemoptysis (HP:0002105) | 2.37602538 |
| 80 | Gingival bleeding (HP:0000225) | 2.37574291 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.34602487 |
| 82 | Petechiae (HP:0000967) | 2.34460303 |
| 83 | Increased IgM level (HP:0003496) | 2.34213775 |
| 84 | Lymphoma (HP:0002665) | 2.33897973 |
| 85 | Pulmonary embolism (HP:0002204) | 2.33395811 |
| 86 | Hematochezia (HP:0002573) | 2.29780607 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.29517394 |
| 88 | Chronic sinusitis (HP:0011109) | 2.28218731 |
| 89 | Abnormal platelet function (HP:0011869) | 2.23238289 |
| 90 | Impaired platelet aggregation (HP:0003540) | 2.23238289 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.22680041 |
| 92 | Chest pain (HP:0100749) | 2.21521345 |
| 93 | Amaurosis fugax (HP:0100576) | 2.17783687 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 2.17506379 |
| 95 | Bronchitis (HP:0012387) | 2.14284455 |
| 96 | Abnormality of the pleura (HP:0002103) | 2.13015578 |
| 97 | Fatigue (HP:0012378) | 2.10398249 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.10284661 |
| 99 | Emphysema (HP:0002097) | 2.10080145 |
| 100 | Anorexia (HP:0002039) | 2.06633915 |
| 101 | Gangrene (HP:0100758) | 2.05173826 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 2.04006360 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 2.02941419 |
| 104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02665747 |
| 105 | Recurrent pneumonia (HP:0006532) | 2.01062556 |
| 106 | Hypoplasia of the thymus (HP:0000778) | 2.00872628 |
| 107 | Skin ulcer (HP:0200042) | 2.00409477 |
| 108 | Abnormal platelet volume (HP:0011876) | 1.99576228 |
| 109 | Sepsis (HP:0100806) | 1.98739684 |
| 110 | Loss of speech (HP:0002371) | 1.97395995 |
| 111 | Restrictive lung disease (HP:0002091) | 1.97077364 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.96606145 |
| 113 | Amyloidosis (HP:0011034) | 1.95482907 |
| 114 | Keratoconjunctivitis (HP:0001096) | 1.95123077 |
| 115 | Increased density of long bones (HP:0006392) | 1.92198888 |
| 116 | Agnosia (HP:0010524) | 1.90143360 |
| 117 | Leukopenia (HP:0001882) | 1.88853010 |
| 118 | Absent frontal sinuses (HP:0002688) | 1.87605266 |
| 119 | Acute myeloid leukemia (HP:0004808) | 1.87380596 |
| 120 | Prostate neoplasm (HP:0100787) | 1.86616923 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86535437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.21281485 |
| 2 | TXK | 3.59751472 |
| 3 | PRPF4B | 3.04545525 |
| 4 | TYK2 | 2.89517491 |
| 5 | JAK3 | 2.77875851 |
| 6 | STK10 | 2.69705763 |
| 7 | KIT | 2.52096878 |
| 8 | ZAP70 | 2.49944986 |
| 9 | MAP3K14 | 2.44384996 |
| 10 | ITK | 2.31127651 |
| 11 | BLK | 2.18661046 |
| 12 | IKBKE | 2.13366638 |
| 13 | IRAK4 | 2.11891012 |
| 14 | JAK1 | 2.06747623 |
| 15 | TBK1 | 2.01871160 |
| 16 | GRK6 | 2.01635389 |
| 17 | BTK | 1.99559207 |
| 18 | SYK | 1.85760724 |
| 19 | MAP3K13 | 1.82638715 |
| 20 | MAP3K10 | 1.82310497 |
| 21 | RIPK4 | 1.79712921 |
| 22 | CSF1R | 1.74622226 |
| 23 | TEC | 1.74563761 |
| 24 | CSK | 1.66689963 |
| 25 | LCK | 1.66678087 |
| 26 | HCK | 1.64850712 |
| 27 | IKBKB | 1.59073139 |
| 28 | TAOK3 | 1.57045562 |
| 29 | EEF2K | 1.56635436 |
| 30 | FGFR4 | 1.55757231 |
| 31 | TGFBR2 | 1.55257578 |
| 32 | FES | 1.47528407 |
| 33 | FGFR3 | 1.46941093 |
| 34 | BMPR2 | 1.46478844 |
| 35 | SIK2 | 1.45299585 |
| 36 | MAP2K3 | 1.35544496 |
| 37 | IRAK3 | 1.33814781 |
| 38 | CLK1 | 1.30675479 |
| 39 | MARK3 | 1.23527181 |
| 40 | PIM1 | 1.23143917 |
| 41 | CDK12 | 1.22464161 |
| 42 | PKN2 | 1.17753095 |
| 43 | PIK3CG | 1.12350677 |
| 44 | LRRK2 | 1.11738083 |
| 45 | LYN | 1.11292451 |
| 46 | ERN1 | 1.02067649 |
| 47 | EPHB1 | 1.01338444 |
| 48 | NLK | 1.00591303 |
| 49 | MAP3K3 | 0.99913193 |
| 50 | CHUK | 0.99610235 |
| 51 | MAP3K1 | 0.98863107 |
| 52 | JAK2 | 0.92265145 |
| 53 | RPS6KA4 | 0.89754608 |
| 54 | CAMKK2 | 0.88196181 |
| 55 | TTN | 0.87156082 |
| 56 | STK4 | 0.87129357 |
| 57 | PRKCQ | 0.85899795 |
| 58 | MAP3K11 | 0.82795788 |
| 59 | TAOK1 | 0.80861583 |
| 60 | MARK2 | 0.80222498 |
| 61 | CDK4 | 0.78870658 |
| 62 | IRAK2 | 0.78846664 |
| 63 | CAMK1D | 0.77244225 |
| 64 | TRIB3 | 0.77035222 |
| 65 | KSR2 | 0.76122030 |
| 66 | PTK6 | 0.73924486 |
| 67 | FLT3 | 0.73413999 |
| 68 | YES1 | 0.72074426 |
| 69 | SMG1 | 0.72057732 |
| 70 | CDK6 | 0.70112291 |
| 71 | TAOK2 | 0.69467791 |
| 72 | NEK9 | 0.67663287 |
| 73 | GRK7 | 0.67357148 |
| 74 | CDC42BPA | 0.67092626 |
| 75 | NEK2 | 0.67015799 |
| 76 | NME2 | 0.65597688 |
| 77 | PRKCH | 0.65536285 |
| 78 | MATK | 0.64702146 |
| 79 | CAMK1G | 0.64202572 |
| 80 | CDK9 | 0.62143803 |
| 81 | CAMKK1 | 0.60731374 |
| 82 | TRPM7 | 0.60464555 |
| 83 | BRD4 | 0.57520909 |
| 84 | MAP3K7 | 0.57491095 |
| 85 | TNK2 | 0.56817052 |
| 86 | PDPK1 | 0.56722708 |
| 87 | PDK1 | 0.56664506 |
| 88 | HIPK2 | 0.55613119 |
| 89 | STK3 | 0.53303010 |
| 90 | MST4 | 0.51415427 |
| 91 | STK24 | 0.50330826 |
| 92 | MAPK7 | 0.49402467 |
| 93 | MAP3K6 | 0.48109175 |
| 94 | SGK2 | 0.47886415 |
| 95 | MAP3K5 | 0.45208374 |
| 96 | TESK2 | 0.44243384 |
| 97 | MELK | 0.43591361 |
| 98 | SIK3 | 0.43292213 |
| 99 | MAP3K2 | 0.42417282 |
| 100 | RPS6KC1 | 0.41564678 |
| 101 | RPS6KL1 | 0.41564678 |
| 102 | EGFR | 0.41035397 |
| 103 | PDGFRB | 0.39989096 |
| 104 | ATR | 0.39935596 |
| 105 | RET | 0.39178702 |
| 106 | MOS | 0.39125391 |
| 107 | ALK | 0.38928648 |
| 108 | EPHA3 | 0.38831064 |
| 109 | WNK1 | 0.38800062 |
| 110 | MAPK12 | 0.38653798 |
| 111 | MAPK4 | 0.37435566 |
| 112 | RAF1 | 0.36861136 |
| 113 | SGK3 | 0.36747082 |
| 114 | FYN | 0.35986487 |
| 115 | MAP3K8 | 0.35321693 |
| 116 | ABL1 | 0.33713483 |
| 117 | PASK | 0.33603203 |
| 118 | RPS6KA6 | 0.32911261 |
| 119 | CDK19 | 0.32196844 |
| 120 | FGR | 0.31683192 |
| 121 | MAPK11 | 0.31215122 |
| 122 | TGFBR1 | 0.29632553 |
| 123 | MAPKAPK2 | 0.29596041 |
| 124 | RIPK1 | 0.27755275 |
| 125 | IRAK1 | 0.27747817 |
| 126 | DMPK | 0.27594014 |
| 127 | IGF1R | 0.26058667 |
| 128 | CDC7 | 0.25530109 |
| 129 | MAPK3 | 0.24408924 |
| 130 | MAP2K6 | 0.23353578 |
| 131 | PRKCD | 0.22732896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.89316404 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.88902115 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66702979 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63695809 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50657213 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.45687563 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.41635591 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.40890446 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38834542 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30597135 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22068556 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03495028 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79408768 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78088266 |
| 15 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73512425 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70764616 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70599444 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69089010 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63936147 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62267445 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60365643 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.58504103 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57180436 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.46110782 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.45860077 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45372228 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42071414 |
| 28 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40494428 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.37809411 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36925633 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.36188110 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.34727715 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31902453 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31582306 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.30930930 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30419194 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29003685 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.26739268 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.24170565 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22761126 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.22248886 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15798861 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12140487 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03432655 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00513181 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99470723 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.94652925 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94219628 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93826784 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93391767 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92411411 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91135299 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90761022 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.89737343 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.88384029 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.87796048 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86925428 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83981387 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82054328 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79167897 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77583881 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76432719 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76414733 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.76268891 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76088636 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73314710 |
| 67 | DNA replication_Homo sapiens_hsa03030 | 0.71771404 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70909145 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69548652 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65352844 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64943358 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64193184 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59297852 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59071778 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.55057099 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54366480 |
| 77 | Mismatch repair_Homo sapiens_hsa03430 | 0.54035505 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53993512 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52825924 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52733693 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52544035 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51007117 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50126181 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49877077 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.47990774 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47603079 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47135359 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46766213 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.46557939 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.45561221 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45483373 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44012285 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43791107 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43309679 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42854562 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42663199 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.42311536 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41678685 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.40613835 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39391675 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39343316 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38701193 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38538388 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38381545 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.37626660 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36620435 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.35987362 |
| 108 | Cell cycle_Homo sapiens_hsa04110 | 0.33687198 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33548210 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32953398 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32604226 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32594306 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.32443495 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30971307 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28947164 |
| 116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25408336 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25229280 |

